Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadar Duskin-Bitan

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|July 20, 2023
Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. ReplyRonen Arbel, Ruslan Sergienko, Doron Netzer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 29, 2020
Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin AntibodiesAmit Ritter, Aviram Mizrachi, Gideon Bachar, et al.
Journal of Clinical Medicine|April 26, 2025
Type 1 Diabetes/Hidradenitis Suppurativa Comorbidity-A Population-Based StudyShany Sherman, Ron Slama, Danielle Bar, et al.
The Lancet. Infectious Diseases|June 23, 2023
Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series studyDan Yamin, Matan Yechezkel, Ronen Arbel, et al.
The Lancet. Infectious Diseases|April 16, 2023
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort studyRonen Arbel, Alon Peretz, Ruslan Sergienko, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2024
Subacute Thyroiditis Following COVID-19 and COVID-19 VaccinationHadar Duskin-Bitan, Eyal Robenshtok, Alon Peretz, et al.
Endocrine|April 8, 2025
Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort studyYaron Rudman, Neta Simon, Rona Shimon, et al.
Clinical Nutrition ESPEN|November 27, 2024
The effect of percentage of time spent above different glucose levels on 90 days mortality of critically ill patients - A retrospective cohort studyLiran Statlender, Eyal Robinson, Allon Grossman, et al.
Endocrine-Related Cancer|March 10, 2025
Increased cancer risk in a cohort of patients with acromegaly in IsraelHadar Duskin-Bitan, Alon Perez, Doron Netzer, et al.
Maturitas|April 8, 2020
Hyperparathyroidism in patients over 75: Clinical characteristics and outcome. Is conservative treatment a safe alternative?Hadar Duskin-Bitan, Nina Nemirovsky, Ilana Slutzky-Shraga, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|July 20, 2023
Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. ReplyRonen Arbel, Ruslan Sergienko, Doron Netzer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 29, 2020
Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin AntibodiesAmit Ritter, Aviram Mizrachi, Gideon Bachar, et al.
Journal of Clinical Medicine|April 26, 2025
Type 1 Diabetes/Hidradenitis Suppurativa Comorbidity-A Population-Based StudyShany Sherman, Ron Slama, Danielle Bar, et al.
The Lancet. Infectious Diseases|June 23, 2023
Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series studyDan Yamin, Matan Yechezkel, Ronen Arbel, et al.
The Lancet. Infectious Diseases|April 16, 2023
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort studyRonen Arbel, Alon Peretz, Ruslan Sergienko, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2024
Subacute Thyroiditis Following COVID-19 and COVID-19 VaccinationHadar Duskin-Bitan, Eyal Robenshtok, Alon Peretz, et al.
Endocrine|April 8, 2025
Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort studyYaron Rudman, Neta Simon, Rona Shimon, et al.
Clinical Nutrition ESPEN|November 27, 2024
The effect of percentage of time spent above different glucose levels on 90 days mortality of critically ill patients - A retrospective cohort studyLiran Statlender, Eyal Robinson, Allon Grossman, et al.
Endocrine-Related Cancer|March 10, 2025
Increased cancer risk in a cohort of patients with acromegaly in IsraelHadar Duskin-Bitan, Alon Perez, Doron Netzer, et al.
Maturitas|April 8, 2020
Hyperparathyroidism in patients over 75: Clinical characteristics and outcome. Is conservative treatment a safe alternative?Hadar Duskin-Bitan, Nina Nemirovsky, Ilana Slutzky-Shraga, et al.
Pageof 4